Trial intelligence / Profile preview

Causticum 200C for Primary Enuresis

NCT02154152Phase 3Unknown

Sponsor
Father Muller Homoeopathic Medical College
Start
May 2014
Primary completion
May 2015
Countries
1
01

Overview

Phase 3, open-label trial in primary nocturnal enuresis (PNE), sponsored by Father Muller Homoeopathic Medical College. Primary endpoint: Frequency of Enuresis at 1 month. Status: unknown.

02

Conditions

primary nocturnal enuresis (PNE)

Beyond the preview

Go deeper on NCT02154152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02154152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call